In this two-part podcast, Dr. Paloma Rodriguez, Cleveland Clinic, sits down with Dr. Andrei Brateanau, Senior Associate Program Director of the Internal Medicine Residency Program in Cleveland Clinic’s Medicine Institute, to discuss evidence that supports the weight-loss effects of metformin in adults with obesity and without type 2 diabetes (T2D).
In this two-part podcast, Dr. Paloma Rodriguez, Cleveland Clinic, sits down with Dr. Andrei Brateanau, Senior Associate Program Director of the Internal Medicine Residency Program in Cleveland Clinic’s Medicine Institute, to discuss evidence that supports the weight-loss effects of metformin in adults with obesity and without type 2 diabetes (T2D).